VIX
19
-6
DRI
63
-3
AVB
39
5
MNST
59
3
RIG
43
3
PSX
25
-12
UA
36
3
FSLR
78
5
CVX
28
3
PEP
32
-3
MHK
45
2
FITB
78
3
ED
42
5
SE
54
5
FLS
63
2
RSG
45
-2
BWA
55
2
HRL
35
12
TEL
69
3
CAG
34
-2
VIX
19
-6
DRI
63
-3
AVB
39
5
MNST
59
3
RIG
43
3
PSX
25
-12
UA
36
3
FSLR
78
5
CVX
28
3
PEP
32
-3
MHK
45
2
FITB
78
3
ED
42
5
SE
54
5
FLS
63
2
RSG
45
-2
BWA
55
2
HRL
35
12
TEL
69
3
CAG
34
-2
Financhill
Back

John Hancock Preferred Income Fund III Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
58

HPS
John Hancock Preferred Income Fund III

Last Price:
$14.52
Seasonality Move:
1.27%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
58
John Hancock Preferred Income Fund III (HPS) is a Buy

Is John Hancock Preferred Income Fund III a Buy, Sell or Hold?

  • The current John Hancock Preferred Income Fund III [HPS] share price is $14.49. The Score for HPS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • HPS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HPS Stock Price Chart

What is John Hancock Preferred Income Fund III's stock price today?

  • The John Hancock Preferred Income Fund III share price today is $14.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HPS is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

HPS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 39.73 Sell
Chaikin Money Flow: 26464 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.45 - 14.89) Sell
Bollinger Bands (100): (14.63 - 15.39) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

HPS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.39 Buy
20-day SMA: 14.63 Sell
50-day SMA: 15.01 Sell
200-day SMA: 14.7 Sell
8-day EMA: 14.44 Buy
20-day EMA: 14.6 Sell
50-day EMA: 14.61 Sell
200-day EMA: 9.58 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

John Hancock Preferred Income Fund III Earnings Growth & HPS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

John Hancock Preferred Income Fund III Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):